Guideline implementation, drug sequencing, and quality of care in heart failure: design and rationale of TITRATE-HF.
Pascal Richard David ClephasJishnu MalgieJeroen SchaapStefan KoudstaalMireille EmansGerard C M LinssenGrytsje A de BoerLoek van HeerebeekC Jan Willem BorleffsOlivier C ManintveldVanessa van EmpelSandra van WijkMieke van den HeuvelCarlos da FonsecaKevin DammanJan van RamshorstRoland van KimmenadeArjen R T van de VenRené A TioDennis van VeghelFolkert W AsselbergsRudolf A de BoerPeter van der MeerStephen J GreeneHans-Peter Brunner-La RoccaJasper J BrugtsPublished in: ESC heart failure (2023)
TITRATE-HF is a real-world multicentre longitudinal registry that will provide unique information on contemporary GDMT implementation, sequencing strategies (order and speed), and prognosis in de novo, worsening, and chronic HF patients.
Keyphrases
- quality improvement
- heart failure
- healthcare
- acute heart failure
- end stage renal disease
- primary care
- ejection fraction
- single cell
- chronic kidney disease
- clinical trial
- newly diagnosed
- palliative care
- cross sectional
- left ventricular
- prognostic factors
- emergency department
- randomized controlled trial
- patient reported outcomes
- chronic pain
- double blind
- electronic health record
- adverse drug